Factor Information
Data ID 3825
Factor the frequency of preablation cardioversions
Description Overall, the frequency of preablation cardioversions in patients who did not have a subsequent recurrence was 52% of that seen in patients who subsequently had a recurrence of IART (0.061 vs. 0.117 cardioversions per patient-month, p=0.0005).
Biomarker NA
Classification A12 (clinical factor - treatment)
Association
Application risk assessment
Objective The objective of the study was to determine the early and midterm success rates of RF ablation in effecting a reduction of clinical arrhythmic events in patients with IART and CHD.
p Value 0.0005
Conclusion Overall, the frequency of preablation cardioversions in patients who did not have a subsequent recurrence was 52% of that seen in patients who subsequently had a recurrence of IART (0.061 vs. 0.117 cardioversions per patient-month, p=0.0005).
Risk Factor unknown
CHD Type
ID 712
CHD Type isolated CHD/non-isolated CHD
CHD Subtype TOF, VSD/TGA/ASD/SV/CHD/other
Reference
PMID 9316535
Year 1997
Title Efficacy of Radiofrequency Ablation for Control of Intraatrial Reentrant Tachycardia in Patients With Congenital Heart Disease
Sample
Population Adults
Source Clinical records
Region Massachusetts, USA.
Method analyzed retrospectively
Race North America
Disease History N/A
Treatment History VSD repair/ASD repair/unrepaired
Group patients who did not have a subsequent recurrence (Treatment) patients who subsequently had a recurrence of IART(Control)
Number 21 19
Age 24.5 ± 10.5 years [range 7.9 to 44.8] 24.5 ± 10.5 years [range 7.9 to 44.8]
Gender (Male: Female) N/A N/A
Marker Level 0.061 0.117